iniparib   Click here for help

GtoPdb Ligand ID: 8360

Synonyms: BSI-201 | SAR240550
PDB Ligand
Compound class: Synthetic organic
Comment: Iniparib was reported as PARP1 inhibitor [2] (or rather its metabolite 4-iodo-3-nitrosobenzamide was reported to inhibit PARP1 activity), however this action has been disputed [1,4].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 86.23
Molecular weight 291.93
XLogP 1.87
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES [O-][N+](=O)c1cc(ccc1I)C(=O)N
Isomeric SMILES [O-][N+](=O)c1cc(ccc1I)C(=O)N
InChI InChI=1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11)
InChI Key MDOJTZQKHMAPBK-UHFFFAOYSA-N
References
1. Liu X, Shi Y, Maag DX, Palma JP, Patterson MJ, Ellis PA, Surber BW, Ready DB, Soni NB, Ladror US et al.. (2012)
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
Clin Cancer Res, 18 (2): 510-23. [PMID:22128301]
2. Mendeleyev J, Kirsten E, Hakam A, Buki KG, Kun E. (1995)
Potential chemotherapeutic activity of 4-iodo-3-nitrobenzamide. Metabolic reduction to the 3-nitroso derivative and induction of cell death in tumor cells in culture.
Biochem Pharmacol, 50 (5): 705-14. [PMID:7669074]
3. O'Shaughnessy J, Osborne C, Pippen JE, Yoffe M, Patt D, Rocha C, Koo IC, Sherman BM, Bradley C. (2011)
Iniparib plus chemotherapy in metastatic triple-negative breast cancer.
N Engl J Med, 364 (3): 205-14. [PMID:21208101]
4. Patel AG, De Lorenzo SB, Flatten KS, Poirier GG, Kaufmann SH. (2012)
Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro.
Clin Cancer Res, 18 (6): 1655-62. [PMID:22291137]